AKERO THERAPEUTICS, INC.
AKERO THERAPEUTICS, INC. is a registered legal entity registered in United States under 4207796, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 30 October 2018 and lists its registered address as SOUTH SAN FRANCISCO, United States. 5 shareholders are on record for AKERO THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 3 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for AKERO THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Janus Henderson Group PLC, holding 10.3% — the largest recorded stake — followed by Blackrock Inc. at 9.3%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 8 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Janus Henderson Group PLC | 10.3% | California Secretary of State — bizfile Online | |
| Blackrock Inc. | 9.3% | California Secretary of State — bizfile Online | |
| Vanguard Group Inc | 7.4% | California Secretary of State — bizfile Online | |
| Wellington Management Group, LLP | 7% | California Secretary of State — bizfile Online | |
| Deep Track Capital, Lp | 6.5% | California Secretary of State — bizfile Online |
Officers
5
The Co-founder & Chief Scientific Officer of AKERO THERAPEUTICS, INC. currently on record is Timothy Rolph; five officers are currently on record for AKERO THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online.
The register reports 18 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at AKERO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
AKERO THERAPEUTICS, INC. sits 3 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark. The full chain up to Novo Nordisk Fonden is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by AKERO THERAPEUTICS, INC.'s own shareholder record.
Novo Nordisk Fonden
Denmark
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns AKERO THERAPEUTICS, INC.?
Five shareholders are currently on record for AKERO THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Janus Henderson Group PLC, holding 10.3% — the largest recorded stake — followed by Blackrock Inc. at 9.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is AKERO THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for AKERO THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does AKERO THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for AKERO THERAPEUTICS, INC.. The register reports 8 in total; only the top 5 by holding are shown here.
What is AKERO THERAPEUTICS, INC.'s company registration number?
AKERO THERAPEUTICS, INC.'s registration number is 4207796, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is AKERO THERAPEUTICS, INC. still an active company?
AKERO THERAPEUTICS, INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was AKERO THERAPEUTICS, INC. incorporated?
AKERO THERAPEUTICS, INC. was incorporated on 30 October 2018, according to California Secretary of State — bizfile Online.
What is AKERO THERAPEUTICS, INC.'s registered address?
The registered address on file for AKERO THERAPEUTICS, INC. is SOUTH SAN FRANCISCO, United States.
Who are the officers/directors of AKERO THERAPEUTICS, INC.?
The Co-founder & Chief Scientific Officer of AKERO THERAPEUTICS, INC. currently on record is Timothy Rolph; five officers are currently on record for AKERO THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online. Management authority at AKERO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does AKERO THERAPEUTICS, INC. have a parent company or subsidiaries?
AKERO THERAPEUTICS, INC. sits 3 levels below its ultimate parent, Novo Nordisk Fonden, registered in Denmark.
Can Zavia monitor changes to AKERO THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to AKERO THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access AKERO THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like AKERO THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 3 October 2026.